Role of RUNX2 in breast cancer development and drug resistance (Review)

被引:4
|
作者
Si, Wentao [1 ]
Kan, Chen [1 ]
Zhang, Leisheng [2 ,3 ,4 ,6 ]
Li, Feifei [1 ,5 ]
机构
[1] Anhui Med Univ, Sch Basic Med Sci, Dept Pathophysiol, Hefei 230032, Anhui, Peoples R China
[2] Gansu Prov Hosp, Key Lab Mol Diagnost & Precis Med Surg Oncol Gansu, Lanzhou 730000, Gansu, Peoples R China
[3] Gansu Prov Hosp, NHC Key Lab Diag & Therapy Gastrointestinal Tumor, Lanzhou 730000, Gansu, Peoples R China
[4] Chinese Acad Sci, Hefei Inst Phys Sci, Key Lab Radiat Technol & Biophys, Hefei 230031, Anhui, Peoples R China
[5] Anhui Med Univ, Sch Basic Med Sci, Dept Pathophysiol, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China
[6] Chinese Acad Sci, Hefei Inst Phys Sci, Key Lab Radiat Technol & Biophys, 350 Shushan Lake Rd, Hefei 230031, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
breast cancer; RUNX2; stem cells; drug resistance; regulatory mechanism; STEM-CELL; TRANSCRIPTION FACTOR; BONE METASTASIS; MYELOID-LEUKEMIA; COMPLEX DISEASES; TUMOR; CD44; HETEROGENEITY; PROLIFERATION; ACTIVATION;
D O I
10.3892/ol.2023.13762
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is the most common malignancy and ranks second among the causes of tumor-associated death in females. The recurrence and drug resistance of breast cancer are intractable due to the presence of breast cancer stem cells (BCSCs), which are adequate to initiate tumor formation and refractory to conventional remedies. Runt-related transcription factor 2 (RUNX2), a pivotal transcription factor in mammary gland and bone development, has also been related to metastatic cancer and BCSCs. State-of-the-art research has indicated the retention of RUNX2 expression in a more invasive subtype of breast cancer, and in particular, triple-negative breast cancer development and drug resistance are associated with estrogen receptor signaling pathways. The present review mainly focused on the latest updates on RUNX2 in BCSCs and their roles in breast cancer progression and drug resistance, providing insight that may aid the development of RUNX2-based diagnostics and treatments for breast cancer in clinical practice.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] ROLE AND REGULATION OF RUNX2 IN OSTEOGENESIS
    Bruderer, M.
    Richards, R. G.
    Alini, M.
    Stoddart, M. J.
    EUROPEAN CELLS & MATERIALS, 2014, 28 : 269 - 286
  • [22] Roles of Runx2 in Skeletal Development
    Komori, Toshihisa
    RUNX PROTEINS IN DEVELOPMENT AND CANCER, 2017, 962 : 83 - 93
  • [23] Cbfβ interacts with Runx2 and has a critical role in bone development
    Kundu, M
    Javed, A
    Jeon, JP
    Horner, A
    Shum, L
    Eckhaus, M
    Muenke, M
    Lian, JB
    Yang, YZ
    Nuckolls, GH
    Stein, GS
    Liu, PP
    NATURE GENETICS, 2002, 32 (04) : 639 - 644
  • [24] Cbfβ interacts with Runx2 and has a critical role in bone development
    Mondira Kundu
    Amjad Javed
    Jae-Pil Jeon
    Alan Horner
    Lillian Shum
    Michael Eckhaus
    Maximilian Muenke
    Jane B. Lian
    Yingzi Yang
    Glen H. Nuckolls
    Gary S. Stein
    P. Paul Liu
    Nature Genetics, 2002, 32 : 639 - 644
  • [25] Role of Runx2 phosphorylation in prostate cancer and association with metastatic disease
    Ge, C.
    Zhao, G.
    Li, Y.
    Li, H.
    Zhao, X.
    Pannone, G.
    Bufo, P.
    Santoro, A.
    Sanguedolce, F.
    Tortorella, S.
    Mattoni, M.
    Papagerakis, S.
    Keller, E. T.
    Franceschi, R. T.
    ONCOGENE, 2016, 35 (03) : 366 - 376
  • [26] Role of Runx2 phosphorylation in prostate cancer and association with metastatic disease
    C Ge
    G Zhao
    Y Li
    H Li
    X Zhao
    G Pannone
    P Bufo
    A Santoro
    F Sanguedolce
    S Tortorella
    M Mattoni
    S Papagerakis
    E T Keller
    R T Franceschi
    Oncogene, 2016, 35 : 366 - 376
  • [27] Investigating RUNX1 and RUNX2 in prostate cancer
    McKillop, Anne Jane
    Edwards, Joanne
    Johnson, Emma
    Mason, Susan
    Cameron, Ewan R.
    Blyth, Karen
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [28] Runx2 in human breast carcinoma: its potential roles in cancer progression
    Onodera, Yoshiaki
    Miki, Yasuhiro
    Suzuki, Takashi
    Takagi, Kiyoshi
    Akahira, Jun-ichi
    Sakyu, Takuya
    Watanabe, Mika
    Inoue, Satoshi
    Ishida, Takanori
    Ohuchi, Noriaki
    Sasano, Hironobu
    CANCER SCIENCE, 2010, 101 (12): : 2670 - 2675
  • [29] RUNX2 Phosphorylation by Tyrosine Kinase ABL Promotes Breast Cancer Invasion
    He, Fang
    Matsumoto, Yoshinori
    Asano, Yosuke
    Yamamura, Yuriko
    Katsuyama, Takayuki
    La Rose, Jose
    Tomonobu, Nahoko
    Komalasari, Ni Luh Gede Yoni
    Sakaguchi, Masakiyo
    Rottapel, Robert
    Wada, Jun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [30] Runx2 Promotes Tumor Growth and Osteolytic Lesions Associated with Breast Cancer
    Pratap, J.
    Imbalzano, K. M.
    Wixted, J. J.
    Gokul, K.
    Hussain, S.
    Underwood, J. M.
    Akech, J.
    van Wijnen, A. J.
    Stein, J. L.
    Imbalzano, A. N.
    Nickerson, J. A.
    Stein, G. S.
    BONE, 2010, 47 : S300 - S301